1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Nuclear Medicine Equipment Market by Product, hybrid PET, & Planar Scintigraphy, Application & by End user - Global Forecasts to 2020

Over the years, the nuclear medicine equipment market has witnessed various advancements in products and their approvals to meet the needs of patients and the radiologists. These advancements have led to the improved use of many existing nuclear medicine equipment as well as the introduction of some new ones.

In 2015, the SPECT systems are expected to account for the largest share of nuclear medicine equipment market, by product; in the SPECT segment the hybrid SPECT systems are likely to command the largest share and are expected to grow at a highest CAGR during the forecast period. Cardiology application segment is expected to account for the largest share of the global nuclear medicine equipment market, by application; the hospitals segment is expected to account for the largest share of the global nuclear medicine equipment market, by end user. Increased adoption of nuclear imaging equipment by hospitals around the world is a major factor for the large share hospitals in the global nuclear medicine equipment market.

In 2015, North America is expected to account for the largest share of the global nuclear medicine equipment market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). In the coming years, the nuclear medicine equipment market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in this region can be attributed to increasing research and development investments, expansion of international players and increasing disease burden and favorable regulatory framework.

The global nuclear medicine equipment market is witnesses’ high competitive intensity with Siemens Healthcare (Germany), Philips Healthcare (Netherlands), and GE Healthcare (U.K.) being the market leaders. Other players include Mediso Medical Imaging Systems, Ltd. (Hungary), Toshiba Medical Systems Corporation (Japan), DDD-Diagnostics A/S (Denmark), Neusoft Medical Systems Co. Ltd. (China), SurgicEye GmbH (Germany), and CMR Naviscan Corporation (U.S.), among others. The players in this market have implemented various strategies to expand their global footprint and increase their market share. The key strategies followed by most of the companies in the nuclear medicine equipment include agreements/partnerships/alliances/collaborations; new product launches; expansions and others.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater markest share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the nuclear medicine equipment market. The report analyzes the nuclear medicine equipment market, by product, application, and end user.

- Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, product approvals, and new product launches in the nuclear medicine equipment market

- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various nuclear medicine equipment across regions

- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the nuclear medicine equipment market

- Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nuclear medicine equipment market

Table Of Contents

Nuclear Medicine Equipment Market by Product, hybrid PET, and Planar Scintigraphy, Application and by End user - Global Forecasts to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH METHODOLOGY STEPS 19
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 20
2.2.1 SECONDARY RESEARCH 20
2.2.1.1 Key data from secondary sources 20
2.2.2 PRIMARY RESEARCH 21
2.2.2.1 Key industry insights 22
2.2.2.2 Key data from primary sources 23
2.2.2.3 Key Insights from primary sources 24
2.3 MARKET SIZE ESTIMATION METHODOLOGY 24
2.4 MARKET DATA VALIDATION AND TRIANGULATION 27
2.5 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
3.1 CURRENT SCENARIO 29
3.2 FUTURE OUTLOOK 31
3.3 CONCLUSION 32
4 PREMIUM INSIGHTS 33
4.1 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET 33
4.2 NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION AND END USER 34
5 MARKET OVERVIEW 36
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.3 MARKET DYNAMICS 38
5.3.1 DRIVERS 38
5.3.1.1 Introduction of new and advanced products 38
5.3.1.2 Investments through public-private partnerships to modernize diagnostic imaging centers 39
5.3.1.3 Advances in radiotracers 40
5.3.1.4 Increasing incidence and prevalence of cancer and cardiac ailments 40
5.3.1.5 Growing geriatric population 40
5.3.1.6 Increasing investments, funds, and grants by government bodies worldwide 41
5.3.2 RESTRAINTS 43
5.3.2.1 High cost of nuclear medicine equipment 43
5.3.2.2 Shorter half-life of radiopharmaceuticals 43
5.3.3 CHALLENGES 44
5.3.3.1 Increasing adoption of refurbished diagnostic imaging systems 44
5.3.3.2 Hospital budget cuts 44
5.3.4 OPPORTUNITIES 45
5.3.4.1 Strong product pipeline 45
5.3.4.2 High demand in emerging markets 46
6 NUCLEAR MEDICINE EQUIPMENT MARKET, BY PRODUCT 47
6.1 INTRODUCTION 48
6.2 SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT) 50
6.2.1 STANDALONE SPECT SYSTEMS 51
6.2.2 HYBRID SPECT SYSTEMS 52
6.3 HYBRID PET 54
6.4 PLANAR SCINTIGRAPHY 55
7 NUCLEAR MEDICINE EQUIPMENT MARKET, BY APPLICATION 56
7.1 INTRODUCTION 57
7.2 CARDIOLOGY 60
7.3 ONCOLOGY 61
7.4 NEUROLOGY 62
7.5 OTHER APPLICATIONS 63
8 NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER 64
8.1 INTRODUCTION 65
8.2 HOSPITALS 66
8.3 IMAGING CENTERS 67
8.4 ACADEMIC AND RESEARCH CENTERS 68
8.5 OTHER END USERS 69

9 NUCLEAR MEDICINE EQUIPMENT MARKET, BY REGION 70
9.1 INTRODUCTION 71
9.2 NORTH AMERICA 73
9.2.1 U.S. 77
9.2.1.1 Increased adoption of nuclear medicine equipment 77
9.2.1.2 Increase in the aging population and rising prevalence of chronic diseases 78
9.2.1.3 Declining reimbursements for radiology 78
9.2.1.4 Unfavorable healthcare reforms 78
9.2.2 CANADA 81
9.2.2.1 High incidence rate chronic diseases 81
9.3 EUROPE 84
9.3.1 EU5 88
9.3.1.1 Increasing number of PET-CT procedures in the U.K. 88
9.3.1.2 Increasing adoption of nuclear medicine equipment 88
9.3.1.3 Increasing incidence and prevalence of cancer 89
9.3.1.4 Increasing investment by stakeholders 89
9.3.1.5 Sluggish growth in healthcare expenditure 89
9.3.2 ROE 92
9.3.2.1 Government and public-private investments 92
9.3.2.2 Increased focus of market players 92
9.3.2.3 Rapid rise in the geriatric population 93
9.4 ASIA-PACIFIC (APAC) 95
9.4.1 JAPAN 99
9.4.1.1 Aging population and high healthcare expenditure in Japan 99
9.4.2 CHINA 102
9.4.2.1 Developing healthcare infrastructure 102
9.4.2.2 Rise in population, prevalence of diseases 102
9.4.2.3 Irregularities in the tendering process 102
9.4.3 INDIA 105
9.4.3.1 High incidence and prevalence of chronic diseases 105
9.4.3.2 Increasing installations of nuclear medicine equipment 105
9.4.3.3 Increasing focus of global market players 105
9.4.3.4 Improving healthcare insurance coverage 106
9.4.3.5 Increasing use of refurbished medical devices a major challenge for market players 106
9.4.4 REST OF ASIA-PACIFIC (ROAPAC) 108
9.4.4.1 Increasing incidence of chronic disease, growing geriatric population 108
9.4.4.2 Favorable regulatory changes in New Zealand and Australia 109
9.4.4.3 Increasing public-private investments 109

9.5 REST OF THE WORLD 112
9.5.1 LATIN AMERICA 113
9.5.1.1 Favorable reimbursement scenario in Brazil 113
9.5.1.2 Consolidation of healthcare service providers in Brazil 113
9.5.1.3 Growing healthcare infrastructure in Latin America 114
9.5.2 THE MIDDLE EAST 114
9.5.3 AFRICA 115
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
10.2 MARKET SHARE ANALYSIS 118
10.3 COMPETITIVE SITUATION AND TRENDS 120
10.3.1 NEW PRODUCT LAUNCHES 122
10.3.2 EXPANSIONS 124
10.3.3 ACQUISITIONS 125
10.3.4 OTHER STRATEGIES 126
11 COMPANY PROFILES 128

(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 128
11.2 PHILIPS HEALTHCARE 129
11.3 SIEMENS AG (SIEMENS HEALTHCARE) 132
11.4 GE HEALTHCARE 135
11.5 DIGIRAD CORPORATION 139
11.6 MEDISO MEDICAL IMAGING SYSTEMS LTD. 141
11.7 SURGICEYE GMBH 142
11.8 TOSHIBA MEDICAL SYSTEMS CORPORATION 144
11.9 DDD-DIAGNOSTIC A/S 146
11.10 NEUSOFT MEDICAL SYSTEMS CO., LTD. 147
11.11 CMR NAVISCAN CORPORATION 149

*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.

12 APPENDIX 150
12.1 DISCUSSION GUIDE 150
12.2 COMPANY DEVELOPMENTS (2012-2015) 155
12.2.1 PHILIPS HEALTHCARE 155
12.2.2 SIEMENS HEALTHCARE 156
12.2.3 GE HEALTHCARE 157
12.2.4 DIGIRAD CORPORATION 158
12.2.5 TOSHIBA MEDICAL SYSTEMS CORPORATION 158
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 159
12.4 AVAILABLE CUSTOMIZATIONS 159
12.5 RELATED REPORTS 160


LIST OF TABLES

TABLE 1 INTRODUCTION OF ADVANCED PRODUCTS IS DRIVING THE GROWTH OF THE NUCLEAR MEDICINE EQUIPMENT MARKET 42
TABLE 2 HIGH COST OF NUCLEAR MEDICINE EQUIPMENT RESTRAINING MARKET GROWTH 43
TABLE 3 GROWING ADOPTION OF REFURBISHED SYSTEMS IS A MAJOR CHALLENGE FOR THE NUCLEAR MEDICINE EQUIPMENT MARKET 44
TABLE 4 EMERGING MARKETS PRESENT AN ARRAY OF OPPORTUNITIES FOR GROWTH OF THE NUCLEAR MEDICINE EQUIPMENT MARKET 46
TABLE 5 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 48
TABLE 6 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (UNITS) 49
TABLE 7 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY REGION,
2013-2020 (USD MILLION) 50
TABLE 8 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE,
2013-2020 (USD MILLION) 50
TABLE 9 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE,
2013-2020 (UNITS) 51
TABLE 10 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR STANDALONE SPECT,
BY REGION, 2013-2020 (USD MILLION) 52
TABLE 11 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HYBRID SPECT,
BY REGION, 2013-2020 (USD MILLION) 53
TABLE 12 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HYBRID PET,
BY REGION, 2013-2020 (USD MILLION) 54
TABLE 13 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR PLANAR SCINTIGRAPHY,
BY REGION, 2013-2020 (USD MILLION) 55
TABLE 14 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 58
TABLE 15 HYBRID PET IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 58
TABLE 16 SPECT IMAGING SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 59
TABLE 17 PLANAR SCINTIGRAPHY SYSTEMS/EQUIPMENT MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 59
TABLE 18 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR CARDIOLOGY, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 19 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR ONCOLOGY, BY REGION, 2013-2020 (USD MILLION) 61
TABLE 20 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR NEUROLOGY, BY REGION, 2013-2020 (USD MILLION) 62
TABLE 21 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR OTHER APPLICATIONS,
BY REGION, 2013-2020 (USD MILLION) 63
TABLE 22 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 65
TABLE 23 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR HOSPITALS,
BY REGION, 2013-2020 (USD MILLION) 66
TABLE 24 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR IMAGING CENTERS,
BY REGION, 2013-2020 (USD MILLION) 67
TABLE 25 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR ACADEMIC and RESEARCH CENTERS, BY REGION, 2013-2020 (USD MILLION) 68
TABLE 26 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR OTHER END USERS,
BY REGION, 2013-2020 (USD MILLION) 69
TABLE 27 NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 71
TABLE 28 NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE,
BY COUNTRY, 2013-2020 ($MILLION) 75
TABLE 29 NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 75
TABLE 30 NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 76
TABLE 31 NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 76
TABLE 32 NORTH AMERICA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE,
BY END USER, 2013-2020 (USD MILLION) 77
TABLE 33 U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 79
TABLE 34 U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 79
TABLE 35 U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 80
TABLE 36 U.S.: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 80
TABLE 37 CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 81
TABLE 38 CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 82
TABLE 39 CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 82
TABLE 40 CANADA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 83
TABLE 41 EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY REGION,
2013-2020 ($MILLION) 86
TABLE 42 EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 86
TABLE 43 EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 87
TABLE 44 EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 87
TABLE 45 EUROPE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 88
TABLE 46 EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 90
TABLE 47 EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 90
TABLE 48 EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 91
TABLE 49 EU5: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 91
TABLE 50 ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 93
TABLE 51 ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT, BY TYPE,
2013-2020 (USD MILLION) 93
TABLE 52 ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 94
TABLE 53 ROE: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 94
TABLE 54 ASIA-PACIFIC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 97
TABLE 55 APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 97
TABLE 56 APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 98
TABLE 57 APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 98
TABLE 58 APAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 99
TABLE 59 JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 100
TABLE 60 JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 100
TABLE 61 JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 101
TABLE 62 JAPAN: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 101
TABLE 63 CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 103
TABLE 64 CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 103
TABLE 65 CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 104
TABLE 66 CHINA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 104
TABLE 67 INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 106
TABLE 68 INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 107
TABLE 69 INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 107
TABLE 70 INDIA: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 108
TABLE 71 ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 109
TABLE 72 ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 110
TABLE 73 ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 110
TABLE 74 ROAPAC: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 111
TABLE 75 ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 115
TABLE 76 ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE FOR SPECT,
BY TYPE, 2013-2020 (USD MILLION) 115
TABLE 77 ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 116
TABLE 78 ROW: NUCLEAR MEDICINE EQUIPMENT MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 116
TABLE 79 AGREEMENTS, JOINT VENTURES, PARTNERSHIPS, COLLABORATIONS, AND ALLIANCES, 2012-2015 121
TABLE 80 NEW PRODUCT LAUNCHES, 2012-2015 123
TABLE 81 EXPANSIONS, 2012-2014 124
TABLE 82 ACQUISITIONS, 2012-2015 125
TABLE 83 OTHER STRATEGIES, 2012-2015 126


LIST OF FIGURES

FIGURE 1 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 22
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 23
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 25
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 25
FIGURE 6 RESEARCH DESIGN 26
FIGURE 7 DATA TRIANGULATION METHODOLOGY 27
FIGURE 8 NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL NUCLEAR MEDICINE EQUIPMENT MARKET IN 2015 30
FIGURE 9 HYBRID PET SEGMENT TO WITNESS HIGHEST GROWTH IN THE NUCLEAR MEDICINE EQUIPMENT MARKET BETWEEN 2015 and 2020 31
FIGURE 10 ASIA-PACIFIC IS EXPECTED TO BE THE FASTEST-GROWING REGIONAL SEGMENT DURING THE FORECAST PERIOD 32
FIGURE 11 NUCLEAR MEDICINE EQUIPMENT MARKET OVERVIEW 33
FIGURE 12 CARDIOLOGY SEGMENT TO DOMINATE THE MARKET IN 2015 34
FIGURE 13 ASIA-PACIFIC POISED TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 35
FIGURE 14 NUCLEAR MEDICINE EQUIPMENT: MARKET SEGMENTATION 37
FIGURE 15 NUCLEAR MEDICINE EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 16 SPECT SEGMENT WILL CONTINUE TO DOMINATE THE NUCLEAR MEDICINE EQUIPMENT MARKET 48
FIGURE 17 CARDIOLOGY SEGMENT IS EXPECTED TO DOMINATE THE NUCLEAR MEDICINE EQUIPMENT MARKET IN 2015 57
FIGURE 18 HOSPITALS SEGMENT PROJECTED TO ACCOUNT FOR MORE THAN 1/3RD OF THE TOTAL NUCLEAR MEDICINE EQUIPMENT MARKET 65
FIGURE 19 SHARE OF GERIATRIC POPULATION IN THE TOTAL POPULATION, 2010 VS. 2030 72
FIGURE 20 NUMBER OF NEW CANCER CASES, BY COUNTRY, 2012 VS. 2020 72
FIGURE 21 INCREASING PREVALENCE OF CANCER IS DRIVING THE MARKET GROWTH IN NORTH AMERICA 73
FIGURE 22 NORTH AMERICAN MARKET SNAPSHOT 74
FIGURE 23 EUROPE: NUMBER OF CANCER CASES REPORTED, BY COUNTRY 84
FIGURE 24 EUROPEAN MARKET SNAPSHOT 85
FIGURE 25 NUMBER OF NEW CANCER CASES, BY TYPE 95
FIGURE 26 ASIA-PACIFIC MARKET SNAPSHOT: CHINA, THE FASTEST-GROWING COUNTRY IN THE NUCLEAR MEDICINE EQUIPMENT MARKET 96
FIGURE 27 ROW MARKET SNAPSHOT 112
FIGURE 28 NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED
BY MARKET PLAYERS BETWEEN 2012 and 2015 117
FIGURE 29 GLOBAL NUCLEAR MEDICINE EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2014 118
FIGURE 30 NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY 120
FIGURE 31 KEY PLAYERS FOCUSING ON AGREEMENTS, COLLABORATIONS, JOINT VENTURES, ALLIANCES, AND PARTNERSHIPS, 2012-2015 121
FIGURE 32 KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCHES, 2012-2015 122
FIGURE 33 KEY PLAYERS FOCUSING ON EXPANSIONS, 2012-2015 124
FIGURE 34 KEY PLAYERS FOCUSING ON ACQUISITIONS, 2012-2015 125
FIGURE 35 KEY PLAYERS FOCUSING ON OTHER STRATEGIES, 2012-2015 126
FIGURE 36 GEOGRAPHIC REVENUE MIX OF THE TOP 3 MARKET PLAYERS 128
FIGURE 37 PHILIPS HEALTHCARE : COMPANY SNAPSHOT 129
FIGURE 38 SIEMENS AG: COMPANY SNAPSHOT 132
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT 135
FIGURE 40 DIGIRAD CORPORATION 139
FIGURE 41 TOSHIBA MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 144
FIGURE 42 NEUSOFT MEDICAL SYSTEMS CO., LTD.: COMPANY SNAPSHOT 147

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.